Researchers discovered that digested SARS-CoV-2 spike protein fragments selectively attack certain immune cells, reducing ...
BURTON, MI, UNITED STATES, January 9, 2026 /EINPresswire.com/ -- Javelin Sciences, a pioneering certified biotechnology ...
SARS-CoV-2, the virus responsible for COVID-19, infects cells by binding its spike protein to angiotensin-converting enzyme 2 (ACE2) receptors. Blocking this interaction with inhibitors could prevent ...
Decisions made by researchers during the microliter, benchtop development of biotherapeutics made from monoclonal antibodies (mAb) and recombinant proteins often don’t scale to larger stirred tank ...
Neutralizing antibodies that merely block receptor binding are losing ground against heavily mutated SARS-CoV-2 Omicron sub-variants. A new approach now exploits a llama-derived nanobody—VHH21—that ...
Researchers at Demokritus University of Thrace, Institute of Applied Biosciences Centre for Research and Technology Hellas, National Hellenic Research Foundation and University of Athens have ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results